Immunological effects of adjuvants in subsets of antigen presenting cells of cancer patients undergoing chemotherapy

BACKGROUND: We have previously shown that HCC patients and healthy subjects are equally responsive to a RNAdjuvant(®), a novel TLR-7/8/RIG-I agonist based on noncoding RNA developed by CureVac, by an ex vivo evaluation. However, the immunological effect of adjuvants on immune cells from cancer patie...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Transl Med
Main Authors: Mauriello, Angela, Manolio, Carmen, Cavalluzzo, Beatrice, Avallone, Antonio, Borrelli, Marco, Morabito, Alessandro, Iovine, Emanuele, Chambery, Angela, Russo, Rosita, Tornesello, Maria Lina, Buonaguro, Franco M., Tagliamonte, Maria, Buonaguro, Luigi
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6977281/
https://ncbi.nlm.nih.gov/pubmed/31973714
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-020-02218-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados